Patients treated with on dupilumab showed significant improvement in sustained BP remission compared with those on placebo.

Dupilumab, an interleukin-4 receptor antagonist, is expected to decrease the type 2 inflammation seen in bullous pemphigoid.

As Sanofi and Regeneron await the FDA decision, a legal dispute between the partners over commercialisation details continues ...

Regeneron and Sanofi said an FDA green light would make Dupixent the first targeted medicine in the U.S. for bullous pemphigoid, a debilitating and relapsing skin disease with underlying type 2 ...

Secured three additional regulatory approvals for world's first chikungunya vaccine, IXCHIQ ® (Canada, Europe, UK); filed adolescent label extension submissions; awarded new $41.3 million grant from ...

Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid If approved, Dupixent would be the first and only targeted medicine to treat BP in the US; FDA decision ...

If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025 Priority Review granted based on positive pivotal results ...

Treatments that don’t involve drugs are also available. These may include talking therapies to help with depression or anxiety, and different forms of treatment (such as cognitive stimulation therapy) ...

A study led by UCL found that individuals with rare diseases were five times more likely to die from Covid-19 than the ...

Today (5 February 2025) NHS England (Midlands) has published the full independent investigation conducted by Theemis into the care and treatment of Valdo Calocane in the months leading up to the ...

Germany stands out within the EU4 and the UK with the highest Bullous Pemphigoid market value, reflecting its central role in the region's treatment landscape. As the market continues to evolve ...

Likewise if you’re under 16 or over 60; you’ve had thrush more than four times in 12 months; you have a weakened immune system; or you’ve tried treatment for thrush and it hasn’t worked ...